FDA NDC Directory · JSON-LD · Markdown

Cisplatin

NDC 68001-283 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerBluePoint Laboratories
Marketing categoryAbbreviated NDA (generic) · App ANDA206774
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsCISPLATIN (1 mg/mL)
Marketing started20160802
Package count2

External sources

Source: openFDA. Public-domain (CC0).